請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/32065
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 呂紹俊(Shao-Chun Lu) | |
dc.contributor.author | Wei-Yu Liao | en |
dc.contributor.author | 廖唯宇 | zh_TW |
dc.date.accessioned | 2021-06-13T03:30:09Z | - |
dc.date.available | 2006-08-04 | |
dc.date.copyright | 2006-08-04 | |
dc.date.issued | 2006 | |
dc.date.submitted | 2006-07-27 | |
dc.identifier.citation | Ahima, R.S. and Flier, J.S. 2000. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 11(8): 327-332.
Al-Daghri, N., Chetty, R., McTernan, P.G., Al-Rubean, K., Al-Attas, O., Jones, A.F., and Kumar, S. 2005. Serum resistin is associated with C-reactive protein & LDL cholesterol in type 2 diabetes and coronary artery disease in a Saudi population. Cardiovasc Diabetol 4(1): 10. Aruna, B., Ghosh, S., Singh, A.K., Mande, S.C., Srinivas, V., Chauhan, R., and Ehtesham, N.Z. 2003. Human recombinant resistin protein displays a tendency to aggregate by forming intermolecular disulfide linkages. Biochemistry 42(36): 10554-10559. Banerjee, R.R. and Lazar, M.A. 2001. Dimerization of resistin and resistin-like molecules is determined by a single cysteine. J Biol Chem 276(28): 25970-25973. Banerjee, R.R., Rangwala, S.M., Shapiro, J.S., Rich, A.S., Rhoades, B., Qi, Y., Wang, J., Rajala, M.W., Pocai, A., Scherer, P.E., Steppan, C.M., Ahima, R.S., Obici, S., Rossetti, L., and Lazar, M.A. 2004. Regulation of fasted blood glucose by resistin. Science 303(5661): 1195-1198. Bokarewa, M., Nagaev, I., Dahlberg, L., Smith, U., and Tarkowski, A. 2005. Resistin, an adipokine with potent proinflammatory properties. J Immunol 174(9): 5789-5795. Calabro, P., Samudio, I., Willerson, J.T., and Yeh, E.T. 2004. Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation 110(21): 3335-3340. Calle, E.E., Thun, M.J., Petrelli, J.M., Rodriguez, C., and Heath, C.W., Jr. 1999. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 341(15): 1097-1105. Chao, L., Marcus-Samuels, B., Mason, M.M., Moitra, J., Vinson, C., Arioglu, E., Gavrilova, O., and Reitman, M.L. 2000. Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones. J Clin Invest 106(10): 1221-1228. Chumakov, A.M., Kubota, T., Walter, S., and Koeffler, H.P. 2004. Identification of murine and human XCP1 genes as C/EBP-epsilon-dependent members of FIZZ/Resistin gene family. Oncogene 23(19): 3414-3425. Conneely, K.N., Silander, K., Scott, L.J., Mohlke, K.L., Lazaridis, K.N., Valle, T.T., Tuomilehto, J., Bergman, R.N., Watanabe, R.M., Buchanan, T.A., Collins, F.S., and Boehnke, M. 2004. Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects. Diabetologia 47(10): 1782-1788. Feinstein, R., Kanety, H., Papa, M.Z., Lunenfeld, B., and Karasik, A. 1993. Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 268(35): 26055-26058. Friedman, J.M. 2002. The function of leptin in nutrition, weight, and physiology. Nutr Rev 60(10 Pt 2): S1-14; discussion S68-84, 85-17. Fujinami, A., Obayashi, H., Ohta, K., Ichimura, T., Nishimura, M., Matsui, H., Kawahara, Y., Yamazaki, M., Ogata, M., Hasegawa, G., Nakamura, N., Yoshikawa, T., Nakano, K., and Ohta, M. 2004. Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes. Clin Chim Acta 339(1-2): 57-63. Fujita, H., Fujishima, H., Morii, T., Koshimura, J., Narita, T., Kakei, M., and Ito, S. 2002. Effect of metformin on adipose tissue resistin expression in db/db mice. Biochem Biophys Res Commun 298(3): 345-349. Gerber, M., Boettner, A., Seidel, B., Lammert, A., Bar, J., Schuster, E., Thiery, J., Kiess, W., and Kratzsch, J. 2005. Serum resistin levels of obese and lean children and adolescents: biochemical analysis and clinical relevance. J Clin Endocrinol Metab 90(8): 4503-4509. Graveleau, C., Zaha, V.G., Mohajer, A., Banerjee, R.R., Dudley-Rucker, N., Steppan, C.M., Rajala, M.W., Scherer, P.E., Ahima, R.S., Lazar, M.A., and Abel, E.D. 2005. Mouse and human resistins impair glucose transport in primary mouse cardiomyocytes, and oligomerization is required for this biological action. J Biol Chem 280(36): 31679-31685. Heilbronn, L.K., Rood, J., Janderova, L., Albu, J.B., Kelley, D.E., Ravussin, E., and Smith, S.R. 2004. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J Clin Endocrinol Metab 89(4): 1844-1848. Hotamisligil, G.S., Shargill, N.S., and Spiegelman, B.M. 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259(5091): 87-91. Husken-Hindi, P., Tsuchida, K., Park, M., Corrigan, A.Z., Vaughan, J.M., Vale, W.W., and Fischer, W.H. 1994. Monomeric activin A retains high receptor binding affinity but exhibits low biological activity. J Biol Chem 269(30): 19380-19384. Ilan, N., Mahooti, S., and Madri, J.A. 1998. Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis. J Cell Sci 111 ( Pt 24): 3621-3631. Jung, H.S., Park, K.H., Cho, Y.M., Chung, S.S., Cho, H.J., Cho, S.Y., Kim, S.J., Kim, S.Y., Lee, H.K., and Park, K.S. 2006. Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovasc Res 69(1): 76-85. Kahn, B.B. and Flier, J.S. 2000. Obesity and insulin resistance. J Clin Invest 106(4): 473-481. Kaser, S., Kaser, A., Sandhofer, A., Ebenbichler, C.F., Tilg, H., and Patsch, J.R. 2003. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 309(2): 286-290. Kim, K.H., Lee, K., Moon, Y.S., and Sul, H.S. 2001. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 276(14): 11252-11256. Lehmann, J.M., Moore, L.B., Smith-Oliver, T.A., Wilkison, W.O., Willson, T.M., and Kliewer, S.A. 1995. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 270(22): 12953-12956. Lehrke, M., Reilly, M.P., Millington, S.C., Iqbal, N., Rader, D.J., and Lazar, M.A. 2004. An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 1(2): e45. Loke, P., Zang, X., Hsuan, L., Waitz, R., Locksley, R.M., Allen, J.E., and Allison, J.P. 2005. Inducible costimulator is required for type 2 antibody isotype switching but not T helper cell type 2 responses in chronic nematode infection. Proc Natl Acad Sci U S A 102(28): 9872-9877. Lu, S.C., Shieh, W.Y., Chen, C.Y., Hsu, S.C., and Chen, H.L. 2002. Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS Lett 530(1-3): 158-162. Moon, B., Kwan, J.J., Duddy, N., Sweeney, G., and Begum, N. 2003. Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation. Am J Physiol Endocrinol Metab 285(1): E106-115. Mu, H., Ohashi, R., Yan, S., Chai, H., Yang, H., Lin, P., Yao, Q., and Chen, C. 2006. Adipokine resistin promotes in vitro angiogenesis of human endothelial cells. Cardiovasc Res 70(1): 146-157. Must, A., Spadano, J., Coakley, E.H., Field, A.E., Colditz, G., and Dietz, W.H. 1999. The disease burden associated with overweight and obesity. Jama 282(16): 1523-1529. Nair, M.G., Gallagher, I.J., Taylor, M.D., Loke, P., Coulson, P.S., Wilson, R.A., Maizels, R.M., and Allen, J.E. 2005. Chitinase and Fizz family members are a generalized feature of nematode infection with selective upregulation of Ym1 and Fizz1 by antigen-presenting cells. Infect Immun 73(1): 385-394. Nystrom, T., Nygren, A., and Sjoholm, A. 2006. Increased levels of tumour necrosis factor-alpha (TNF-alpha) in patients with Type II diabetes mellitus after myocardial infarction are related to endothelial dysfunction. Clin Sci (Lond) 110(6): 673-681. Oral, E.A., Simha, V., Ruiz, E., Andewelt, A., Premkumar, A., Snell, P., Wagner, A.J., DePaoli, A.M., Reitman, M.L., Taylor, S.I., Gorden, P., and Garg, A. 2002. Leptin-replacement therapy for lipodystrophy. N Engl J Med 346(8): 570-578. Pagano, C., Marin, O., Calcagno, A., Schiappelli, P., Pilon, C., Milan, G., Bertelli, M., Fanin, E., Andrighetto, G., Federspil, G., and Vettor, R. 2005. Increased serum resistin in adults with prader-willi syndrome is related to obesity and not to insulin resistance. J Clin Endocrinol Metab 90(7): 4335-4340. Palanivel, R. and Sweeney, G. 2005. Regulation of fatty acid uptake and metabolism in L6 skeletal muscle cells by resistin. FEBS Lett 579(22): 5049-5054. Pasceri, V., Willerson, J.T., and Yeh, E.T. 2000. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102(18): 2165-2168. Patel, S.D., Rajala, M.W., Rossetti, L., Scherer, P.E., and Shapiro, L. 2004. Disulfide-dependent multimeric assembly of resistin family hormones. Science 304(5674): 1154-1158. Perseghin, G., Burska, A., Lattuada, G., Alberti, G., Costantino, F., Ragogna, F., Oggionni, S., Scollo, A., Terruzzi, I., and Luzi, L. 2006. Increased serum resistin in elite endurance athletes with high insulin sensitivity. Diabetologia. Rajala, M.W., Obici, S., Scherer, P.E., and Rossetti, L. 2003. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest 111(2): 225-230. Ravussin, E. and Smith, S.R. 2002. Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann N Y Acad Sci 967: 363-378. Reaven, G.M. 1993. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 44: 121-131. Reginato, M.J. and Lazar, M.A. 1999. Mechanisms by which Thiazolidinediones Enhance Insulin Action. Trends Endocrinol Metab 10(1): 9-13. Reinehr, T., Roth, C.L., Menke, T., and Andler, W. 2006. Resistin concentrations before and after weight loss in obese children. Int J Obes (Lond) 30(2): 297-301. Rubanyi, G.M. and Polokoff, M.A. 1994. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 46(3): 325-415. Saltiel, A.R. 2001. You are what you secrete. Nat Med 7(8): 887-888. Sato, C., Yasukawa, Z., Honda, N., Matsuda, T., and Kitajima, K. 2001. Identification and adipocyte differentiation-dependent expression of the unique disialic acid residue in an adipose tissue-specific glycoprotein, adipo Q. J Biol Chem 276(31): 28849-28856. Sato, N., Kobayashi, K., Inoguchi, T., Sonoda, N., Imamura, M., Sekiguchi, N., Nakashima, N., and Nawata, H. 2005. Adenovirus-mediated high expression of resistin causes dyslipidemia in mice. Endocrinology 146(1): 273-279. Scherer, P.E., Williams, S., Fogliano, M., Baldini, G., and Lodish, H.F. 1995. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270(45): 26746-26749. Shuldiner, A.R., Yang, R., and Gong, D.W. 2001. Resistin, obesity and insulin resistance--the emerging role of the adipocyte as an endocrine organ. N Engl J Med 345(18): 1345-1346. Silswal, N., Singh, A.K., Aruna, B., Mukhopadhyay, S., Ghosh, S., and Ehtesham, N.Z. 2005. Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun 334(4): 1092-1101. Smith, U. 2002. Impaired ('diabetic') insulin signaling and action occur in fat cells long before glucose intolerance--is insulin resistance initiated in the adipose tissue? Int J Obes Relat Metab Disord 26(7): 897-904. Stejskal, D., Adamovska, S., Bartek, J., Jurakova, R., and Proskova, J. 2003. Resistin - concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 147(1): 63-69. Steppan, C.M., Bailey, S.T., Bhat, S., Brown, E.J., Banerjee, R.R., Wright, C.M., Patel, H.R., Ahima, R.S., and Lazar, M.A. 2001a. The hormone resistin links obesity to diabetes. Nature 409(6818): 307-312. Steppan, C.M., Brown, E.J., Wright, C.M., Bhat, S., Banerjee, R.R., Dai, C.Y., Enders, G.H., Silberg, D.G., Wen, X., Wu, G.D., and Lazar, M.A. 2001b. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci U S A 98(2): 502-506. Steppan, C.M., Wang, J., Whiteman, E.L., Birnbaum, M.J., and Lazar, M.A. 2005. Activation of SOCS-3 by resistin. Mol Cell Biol 25(4): 1569-1575. Tontonoz, P., Hu, E., and Spiegelman, B.M. 1994. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79(7): 1147-1156. Trayhurn, P. and Beattie, J.H. 2001. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 60(3): 329-339. Valsamakis, G., McTernan, P.G., Chetty, R., Al Daghri, N., Field, A., Hanif, W., Barnett, A.H., and Kumar, S. 2004. Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines. Metabolism 53(4): 430-434. Verma, S., Li, S.H., Wang, C.H., Fedak, P.W., Li, R.K., Weisel, R.D., and Mickle, D.A. 2003. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 108(6): 736-740. Vishwanathan, V. 2002. Current and future perspective in the management of diabetes. J Indian Med Assoc 100(3): 181-183. Wang, Y., Xu, A., Knight, C., Xu, L.Y., and Cooper, G.J. 2002. Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. Potential role in the modulation of its insulin-sensitizing activity. J Biol Chem 277(22): 19521-19529. Way, J.M., Gorgun, C.Z., Tong, Q., Uysal, K.T., Brown, K.K., Harrington, W.W., Oliver, W.R., Jr., Willson, T.M., Kliewer, S.A., and Hotamisligil, G.S. 2001. Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 276(28): 25651-25653. Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R.E., and Tataranni, P.A. 2001. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86(5): 1930-1935. Wiecek, A., Kokot, F., Chudek, J., and Adamczak, M. 2002. The adipose tissue--a novel endocrine organ of interest to the nephrologist. Nephrol Dial Transplant 17(2): 191-195. Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., Ezaki, O., Akanuma, Y., Gavrilova, O., Vinson, C., Reitman, M.L., Kagechika, H., Shudo, K., Yoda, M., Nakano, Y., Tobe, K., Nagai, R., Kimura, S., Tomita, M., Froguel, P., and Kadowaki, T. 2001. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7(8): 941-946. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., and Friedman, J.M. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature 372(6505): 425-432. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/32065 | - |
dc.description.abstract | Resistin在動物實驗中被認為是肥胖時由脂肪細胞所分泌而造成第二型糖尿病的重要因子。但是多數的臨床研究顯示,human resistin似乎和發炎反應較具有相關性,而與肥胖或糖尿病沒有明顯的相關性。因此resistin也被認為是屬於和發炎有關的細胞激素之ㄧ。近幾年的研究中多利用大腸桿菌表現的recombinant human resistin (rhResistin)來探討其功能,並觀察到rhResistin會促進肝臟的糖質新生,也會造成心血管內皮細胞的細胞附著分子表現量上升以及促進心血管平滑肌細胞的細胞增生。Resisitn有十一個cysteines,這些cysteines當中的十個cysteines會形成五對的分子內雙硫鍵,剩下的一個cysteine會形成一對的分子間雙硫鍵而造成dimer的形式,這些dimer則可以再聚合成hexamer 。我們懷疑由大腸桿菌所表現之rhResistin即使再refolding之後是否真能準確的摺疊成哺乳類細胞所表現出來的hexameric resistin相同。首先我們將於大腸桿菌和293T細胞中大量表現的rhResistin以Ni-NTA純化出並以sliver stain的方式分析其純度。也以LC/MS/MC確定其為rhResistin。再將自大腸桿菌、293T細胞純化後的rhResistin以及英國PeproTech生技公司所提供之E.coli expressed rhResistin分別以superose 6和superose 12 管柱分析,發現只有自293T細胞所表現之rhResistin才會形成hexamer的形式,而由大腸桿菌所表現的rhResistin則是不會形成hexamer的形式。以non-denaturing or denaturing的 SDS-PAGE分析發現,由大腸桿菌所表現的rhResistin較容易形成aggregates,由293T所表現的rhResistin則沒有這種現象。因此,爲了解由大腸桿菌以及293T細胞所表現rhResistin在發炎以及細胞增生有關的生物活性上是否相同,我們比較由293T細胞所表現的rhResistin之conditional medium和英國PeproTech生技公司所提供的大腸桿菌所表現之rhResistin對Raw264.7細胞株之與發炎有關基因的表現以及心血管內皮細胞增生情況的影響。實驗結果發現,以生技公司所提供之rhResistin處理Raw 264.7細胞會使得TNF-α以及IL-6之mRNA表現上升,也會提高人類內皮細胞之細胞增生。若以293T表現之rhResistin的conditional medium來細胞處理,會發現到單只是pcDNA3 myc-His vector only conditional medium的情況下欲觀察之基因其表現情況皆會大量上升,導致我們無法有效地比較在conditional medium作為背景值的情況之下,293T細胞以及大腸桿菌表現之rhResistin在生物活性上影響為何。因此接下來我們利用純化後的293T細胞所表現rhResistin去處理細胞並比較與生技公司所提供之rhResistin在活性上的差異,我們觀察到293T表現rhResistin似乎是比生技公司所提供之rhResistin更能促進Raw264.7細胞TNF-α、resistin及iNOS等基因之mRNA表現,但兩者對於造成HCAECs的增生並沒有差異。因此未來我們將以純化的293T表現rhResistin來處理細胞,再進一步觀察並釐清由293T所表現之rhResistin與E.coli表現之rhResistin在生物活性上有何異同。 | zh_TW |
dc.description.abstract | Resistin has been identified to be synthesized and secreted in adipocytes, and was thought to be a link of obesity and diabetes in mouse. However, clinical studies did not support that resistin link obesity and type II diabetes in human. Several lines of evidences suggest that resistin may play a role in inflammation. However, the physiological function of rhResistin is still unclear. Recently, functional studies using E.coli rhResistin suggested that the resistin may increase gluconeogenesis in the liver, increase production of adhesion molecules by aortic endothelial cells and increase proliferation of aortic smooth muscle cells. Resistin, which has 11 cysteines, contains five intramolecular disulfide bonds through ten cysteines and forms homo-dimmer through an intermolecular disulfide bond. And three dimers form a hexamer. We speculate that E.coli expressed rhResistin may not fold correctly and form hexamer as that produced by mammalian cells. Therefore, biological function tested using a E.coli expressed rhResistin may be different from that using rhResistin expressed by mammalian cells. The aims of this study are to investigate the structure and function of rhResistin protein produced by 293T cells or E.coli. We purified rhResistin from E.coli and 293T cells using Ni-NTA and analysed the degree of purity by sliver stain. The purified rhResistin were confirmed by LC/MS/MS. Gel filtration analysis of purified rhResistin from E.coli, 293T cells or purchased from PeproTech(E.coli expressed) using superose 6 or superose 12 column. The results show that 293T expressed rhResistin were eluted at ~75KD, however, E.coli expressed rhResistin was eluted at ~40kDa. The results suggest that 293T expressed rhResistin are a hexamer, but the E.coli expressed rhResistin do not form hexamer structure. In non-denaturing or denaturing SDS-PAGE, 293T expressed rhResistin show dimmer and monomer but E.coli expressed rhResistin tend to aggregate. Furthermore, we compared the biological activity of rhResistin from PeproTech (E.coli expressed) or 293T expressed rhResistin in promotion of inflammation in Raw264.7 cells and cell proliferation in aortic endothelial cells. We treated cells using conditional medium of rhResistin transfected 293T cells and E.coli expressed rhResistin from PeproTech. Our preliminary data show that E.coli expressed rhResistin induced TNF-α and IL-6 mRNA production in mouse macrophages and induce human endothelial cell proliferation. However, we were unable to clarify the effects of rhResistin expressed by 293T cells. Because the levels of TNF-α, IL-6, resistin and iNOS mRNA were increased when Raw264.7 cells were treated with conditional medium from cells transfected with pcDNA3 myc-His vector. Then we treated Raw 264.7 and HCAEC with the purified 293T expressed rhResistin and found that purified 293T expressed rhResistin induced more TNF-α, resistin and iNOS mRNA expression in Raw264.7 cell than E.coli expressed rhResistin from PeproTech. In future, we will compare the biological function of purified rhResistin from 293T cell and E.coli. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T03:30:09Z (GMT). No. of bitstreams: 1 ntu-95-R93442012-1.pdf: 5898623 bytes, checksum: fb53765d5295603cc7c522a0d7f185d4 (MD5) Previous issue date: 2006 | en |
dc.description.tableofcontents | 中文摘要 1
英文摘要 3 縮寫對照表 5 第一章 緒論 8 第一節、文獻回顧 9 一、緒言 9 二、糖尿病 9 三、肥胖與糖尿病 11 四、Resistin 12 1、 Resistin的發現 12 2、 Resistin的生化特性 13 3、 小鼠resistin的生理作用 14 4、 人類resistin的臨床分析 15 5、 人類resistin與發炎反應 16 6、 Resistin與心血管疾病 17 7、 Resistin結構和功能 18 第二節、研究動機與實驗目的 20 第二章 實驗方法 21 第一節、實驗材料 22 第二節、293T細胞表現之recombinant human resistin 24 一、rhResistin表現質體之建構 24 二、293T細胞rhResistin之表現 24 三、293T細胞表現rhResistin之純化 25 第三節、利用大腸桿菌表現rhResistin和rmResistin 26 一、rmResistin表現質體之建構 26 二、rhResistin表現質體之建構與表現 27 三、誘導大腸桿菌rhResistin和rmResistin之表現 32 四、大腸桿菌表現rhResistin和rmResistin之純化 33 第四節、比較293T細胞表現之rhResistin 和大腸桿菌表現之 rhResistin和rmResistin間的結構上差異 34 一、十二烷硫酸鈉聚丙烯醯胺凝膠電泳法(SDS-PAGE)—銀染 色法與Coomassie blue染色法 34 二、西方墨點法(Western blot) 37 三、墨點法(Dot Blot) 38 四、凝膠管柱層析(gel filtration) 39 五、陰離子交換樹酯 39 第五節、探討293T細胞表現之rhResistin 和英國PEPROTECH生技 公司之大腸桿菌表現之rhResistin對人類動脈血管內皮 細胞及小鼠巨噬細胞的影響 39 一、比較293T細胞表現之rhResistin 和英國PEPROTECH生 技公司之大腸桿菌表現之rhResistin對小鼠巨噬細胞 中細胞激素之mRNA的影響 39 二、比較293T細胞表現之rhResistin 和英國PEPROTECH生 技公司之大腸桿菌表現之rhResistin對人類動脈血管 內皮細胞增殖的影響 42 第六節、統計分析 43 第三章 實驗結果 44 一、 Human resistin cDNA之選殖及E.coli表現human r-(His)6- resistin重組蛋白之製備 45 二、 E.coli表現之rhResistin和rmResistin與293T細胞表現之 rhResistin之covlaent以及non-covalent interaction的差 異 46 三、 E.coli表現之rhResistin和rmResistin與293T細胞表現之 rhResistin在native狀態下分子量的差異 46 四、 293T細胞所表現的rhResistin與E.coli表現之rhResistin在生 物活性上的比較 48 第四章 圖表 51 第五章 討論 72 第六章 參考文獻 79 圖 目 錄 Figure 1. The vectors used for expression for human resistin in E.coli (pQE-31) or in 293T cell (pcDNA3.1/myc-His) or mouse resistin in E.coli (pET-15b). 52 Figure 2. The cloning of pQE31 His-hRstn construct. 53 Figure 3. Expression of rhResistin or rmResistin in E.coli. 54 Figure 4. E.coli expressed rhResistin (h) or rmResistin (m) displays a tendency to aggregate. 55 Figure 5. Purification of rmResistin (a) and rhResistin (b) from E.coli. 56 Figure 6. DEAE cellulose anion-exchange column chromatography and SDS-PAGE analysis of Ni-NTA chromatography purified proteins. 57 Figure 7. Gel filtration analysis of E.coli expressed rmResistin by using a Suprose 6 column. 58 Figure 8. Gel filtration analysis of E.coli expressed rhResistin by using a Suprose 6 column. 59 Figure 9. Purification of rhResistin from culture media (serum free) of 293T cells that transfected with pcDNA3.1-hRstn-myc-His. 60 Figure 10. The protein eluted with 250 mM imidazole was detected by Western blot. 61 Figure 11. The rhResistin expressed by 293T cells. 62 Figure 12. Gel filtration analysis of purified rhResistin expreesed by 293 T cells using a Superose 12 column. 63 Figure 13. (a)Gel filtration analysis of E.coli expressed rhResistin from PeproTech EC® using a Superose 12 column. (b) SDS-PAGE with siliver staining analysis of commercial E.coli expressed rhResistin. 64 Figure 14. rhResistin stimulates the synthesis of cytokine and iNOS mRNA 65 Figure 15. Semi-quantitaive analysis of rhResistin. 66 Figure 16. pcDNA-myc-His vector only conditional medium, pcDNA-myc-His vector only conditional medium with commercial E.coli expressed rhResistin, pcDNA-hRstn-myc-His conditional medium, and bFGF stimulate the synthesis of cytokine mRNA. 67 Figure 17. Effect of rhResistin, bFGF and VEGF on [3H]thymidine incorporation in HCAECs. 68 Figure 18. Effect of pcDNA-myc-His vector only conditional medium, pcDNA-myc-His vector only conditional medium with commercial E.coli expressed rhResistin, pCDNA-hRstn-myc-His conditional medium, and bFGF on [3H]thymidine incorporation in HCAECs. 69 Figure 19. 293T cell and E.coli expressed rhResistin stimulate the synthesis of cytokine mRNA. 70 Figure 20. Effect of 293T cell and E.coli expressed rhResistin on [3H]thymidine incorporation in HCAECs. 71 | |
dc.language.iso | zh-TW | |
dc.title | 比較E.coli與293T cell表現之人類resistin在結構上及功能上的差異 | zh_TW |
dc.title | Structural and functional comparison of human resistin expressed by E.coli and 293T cell | en |
dc.type | Thesis | |
dc.date.schoolyear | 94-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 廖大修(Ta-Hsiu Liao),李明學(Ming-Shyue Lee),張淑芬(Shwu-Fen Chang),姜安娜(An-Na Chiang) | |
dc.subject.keyword | 蛋白純化,膠體過濾, | zh_TW |
dc.subject.keyword | resistin,nickel column,hexamer,dimer, | en |
dc.relation.page | 85 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2006-07-28 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 生物化學暨分子生物學研究所 | zh_TW |
顯示於系所單位: | 生物化學暨分子生物學科研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-95-1.pdf 目前未授權公開取用 | 5.76 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。